Skip to main content
OpenTrials
Completed

NCT Number: NCT03333629

Promoting Positive Outcomes for Individuals With ASD: Linking Early Detection, Treatment, and Long-term Outcomes

Autism spectrum disorder (ASD) is defined by impaired social engagement and social communication, and repetitive, restricted, or stereotyped behaviors and interests. The average age of diagnosis in the US is after the fourth birthday. However, children who start ASD-specific early intervention have better outcomes than children start later. The current study will address a gap identified by the US Prevention Services Task Force, namely that children detected through screening respond positively to early intervention. This study will directly relate early detection strategies to early intervention, and measure the impact of age of intervention onset on outcomes when children are entering kindergarten. Local pediatric providers will be randomized to provide either usual care, or to an experimental condition in which autism early detection strategies are enhanced through the addition of specific procedures. Across all sites, 8,000 children will be recruited through their participating pediatric practice. Qualifying children will receive up to one year of early intensive behavioral intervention, after getting an ASD diagnosis. Primary outcome measures will include children's cognitive functioning and ASD symptom severity, which will be measured at multiple time points. The investigators predict that this study will inform early detection strategies which will result in improving children's social and cognitive functioning, mitigating lifespan disability, reducing societal costs, and improving personal well-being and productivity of individuals with ASD.

Completed

Looking for future studies?

Notify Me

Key information

Age range

16 month–58 month

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

University of California, Davis, Sacramento, California, United States

Loading trial locations.

About this study

Autism spectrum disorder (ASD) is a serious neurodevelopmental disorder defined by impaired social engagement and social communication, in addition to the presence of repetitive, restricted, or stereotyped behaviors and interests. Although many cases of ASD can be detected when children are less than two years old, the average age of diagnosis in the US is still after the fourth birthday. However, evidence demonstrates that children who start ASD-specific early intervention have better outcomes than children who do not start treatment until later ages. In 2006 and 2007, American Academy of Pediatrics recommended three early detection approaches to improve identification of children at risk for ASD: ongoing developmental surveillance at every well-child check-up, routine broad developmental screening at three infant/toddler ages, and ASD-specific screening at two toddler ages. When these early detection strategies are used with all children attending well-child check-ups, the age of ASD detection is lower, and children who are diagnosed have the opportunity to start ASD-specific early intervention at younger ages than if they had not been detected. Yet in 2016, the US Preventive Services Task Force (USPSTF) indicated that current evidence is insufficient to recommend universal ASD screening, given the lack of experimental studies demonstrating positive outcomes for treated children that are detected through screening. The current study will address this gap. This study will directly relate early detection strategies to early intervention, and measure the impact of age of intervention onset on outcomes when children are entering kindergarten. The study will be conducted by investigators from three sites: Drexel University; the University of California, Davis; and the University of Connecticut. Local pediatric providers will be enrolled in the study, and their practices will be randomized to provide either usual care, or to an experimental condition in which autism early detection strategies are enhanced through the addition of specific procedures. Children attending well-child visits at participating practices will then be enrolled. Across all sites, 8,000 children will be recruited through their participating pediatric practice. As part of the study, qualifying children will receive up to one year of early intensive behavioral intervention, using an evidence-based manualized treatment. Primary outcome measures will include children's cognitive functioning and ASD symptom severity, which will be measured at multiple time points. Exploratory outcomes will include children's adaptive functioning, kindergarten readiness, and social reciprocity, as measured by experimental eye tracking and parent-child interaction ratings. This study also will examine the impact of the screening intervention on physician attitudes and on parent empowerment and stress. Finally, investigators will examine potential moderators of outcomes, to determine whether initial symptom severity, cognitive ability, or socioeconomic status affects children's long-term outcomes. The investigators predict that this study will inform early detection strategies which will result in improving children's social and cognitive functioning, mitigating lifespan disability, reducing societal costs, and improving personal well-being and productivity of individuals with ASD.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • child attended 18 m visiting at participating pediatric practice
  • legal guardian is fluent in English or Spanish

Exclusion criteria

  • child has severe sensory or motor deficit that precludes completing standardized evaluation

Treatment and study plan

Enhanced early detection

Behavioral

standardized screening

Primary outcomes

  1. Change in ASD Symptom Severity

    Time frame: Change from pre-treatment to immediately post-treatment; 10 minutes

    ASD symptom severity will be measured with the Brief Observation of Social Communication Change (BOSCC)

  2. Change in Cognitive Functioning

    Time frame: Change from pre-treatment to immediately post-treatment; 60 minutes

    Cognitive functioning will be measured by the Mullen Scales of Early Learning (MSEL).

Secondary outcomes

  1. Adaptive Functioning

    Time frame: Immediately post-treatment, 48 m, 60 m; 45 minutes

    Vineland Adaptive Behavior Scales-3

  2. ASD Symptoms - secondary measure1

    Time frame: 48 m, 60 m; 45 minutes

    Autism Diagnostic Observation Schedule, Second Edition (ADOS-2)

  3. Kindergarten Readiness

    Time frame: 60 m; 45 minutes

    Developmental Indicators for the Assessment of Learning-4

  4. Social Engagement

    Time frame: Immediately post-treatment, 48 m, 60 m; 15 minutes

    Eye tracking paradigms will assess aspects of social engagement (i.e., social orienting, motivation, and cognition)

  5. Long-term change in Cognitive Functioning

    Time frame: 48 m, 60 m; 60 minutes

    Cognitive functioning will be measured by the Mullen Scales of Early Learning (MSEL)

  6. Parent-Child Social Engagement

    Time frame: Immediately post-treatment, 48 m, 60 m; 15 minutes

    Parent-child social engagement will be measured with the Joint Engagement Rating Inventory, which is applied to video recordings of the Communication Play Protocol.

  7. ASD symptoms - secondary measure2

    Time frame: Immediately post-treatment, 48 m, 60 m; 20 minutes

    PDD Behavior Inventory

  8. ASD symptoms - secondary measure3

    Time frame: 48 m, 60 m; 10 minutes

    BOSCC

  9. Long-term change in Cognitive Functioning (alternative)

    Time frame: 48 m, 60 m; 60 minutes

    and for children who reach ceiling on the MSEL, we will use the Differential Differential Abilities Scales-II (DAS-II) will be used for children too advanced for Outcome 7

Sponsors and collaborators

Lead sponsor

Drexel University

Other

Collaborators

  • University of California, Davis
  • University of Connecticut

Registry information

Official study title

Connecting the Dots: An RCT Integrating Standardized ASD Screening, High-Quality Treatment, and Long-Term Outcomes

Important dates

Study start
2017
Primary completion
2023
Study completion
2024
First posted
Nov 7, 2017
Registry last updated
Aug 16, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.